Invesco
ELOS

Invesco’s Syneron Medical Ltd ELOS Stock Holding History

Invesco’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-32,671
Closed -$274K – 3802
2016
Q4 		$274K Sell
32,671
-476
-1% -$3.73K ﹤0.01% 3487
2016
Q3 		$237K Buy
33,147
+6,426
+24% +$44.7K ﹤0.01% 3502
2016
Q2 		$205K Sell
26,721
-476
-2% -$3.39K ﹤0.01% 3530
2016
Q1 		$199K Buy
27,197
+5,933
+28% +$42.5K ﹤0.01% 3563
2015
Q4 		$164K Buy
21,264
+696
+3% +$5.31K ﹤0.01% 3606
2015
Q3 		$147K Buy
20,568
+696
+4% +$6.69K ﹤0.01% 3650
2015
Q2 		$211K Buy
19,872
+2,602
+15% +$30.5K ﹤0.01% 3710
2015
Q1 		$214K Buy
17,270
+1,000
+6% +$11.1K ﹤0.01% 3666
2014
Q4 		$152K Buy
16,270
+834
+5% +$8.04K ﹤0.01% 3716
2014
Q3 		$155K Buy
15,436
+858
+6% +$8.73K ﹤0.01% 3754
2014
Q2 		$150K Hold
14,578
– – ﹤0.01% 3829
2014
Q1 		$181K Buy
14,578
+1,638
+13% +$19.4K ﹤0.01% 3802
2013
Q4 		$159K Buy
12,940
+1,452
+13% +$15.1K ﹤0.01% 3886
2013
Q3 		$99K Buy
11,488
+1,224
+12% +$10.6K ﹤0.01% 4007
2013
Q2 		$89K Buy
+10,264
New +$91.8K ﹤0.01% 3980

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Invesco's ELOS Position: Q1 2017 in Review

Invesco sold out of Syneron Medical Ltd (ELOS) in Q1 2017, closing a stake of 32,671 shares — an estimated $274K sold.

Invesco first reported a position in ELOS in Q2 2013 and held it in 15 quarters. The position peaked at $274K in Q4 2016. 91 funds tracked by Wall St. Rank hold ELOS as of Q1 2017.

  • Invesco reported no remaining Syneron Medical Ltd position as of Q1 2017 after selling out during the quarter.
  • Invesco sold 32,671 Syneron Medical Ltd shares in Q1 2017, an estimated $274K.
  • Invesco first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 15 quarters.
  • Invesco's Syneron Medical Ltd position peaked at $274K in Q4 2016.
  • 91 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q1 2017.

Based on Invesco's 13F filing for Q1 2017, filed 15 May 2017.